Tag Archives: breast cancer treatment
We should have access to essential medical supplies
By Tibby Reas Hinderlie, Communications Manager
For many people, breast cancer treatment comes with harsh, disabling side effects.
Lymphedema is a condition that causes incredibly painful swelling in the arms or legs due to the blocked flow of fluids. It is estimated... Read more
Posted in BCA Action Alerts, E-Alerts
Check out our newly revised free resource
By Zoë Christopher, Program Officer & Operations Manager
Our latest resource, What You Need to Know About Breast Cancer, provides our unbiased, patient-centered take on the basics of breast cancer, free from industry influence.
We’ve recently updated this... Read more
Posted in E-Alerts
SABCS 2020: Why More Tests Won’t Solve the Breast Cancer Epidemic and Other Takeaways
By Karuna Jaggar, Former Executive Director and SABCS Guest Writer
In our “take action,” “more is better,” “gotta do something” culture, most people assume that more medial testing will lead to better treatments. After all, many assume, the more we know about a... Read more
Posted in Articles
SABCS 2020
By Jayla Burton, Program Officer
For decades billions of dollars have been poured into breast cancer research. And each December clinicians and researchers from around the world gather at the San Antonio Breast Cancer Symposium (SABCS) to share the latest study results. For... Read more
SABCS 2020: Immunotherapy Part 4 – Sacituzumab Govitecan Improves Overall Survival for Metastatic Triple Negative Breast Cancer
By Karuna Jaggar, Former Executive Director and SABCS Guest Writer
In April 2020, the FDA approved a new type of immunotherapy, the antibody drug conjugate sacituzumab govitecan (brand name Trodelvy), a name so unpronounceable that even doctors at SABCS struggled and generally... Read more
Posted in Articles
SABCS 2020: Immunotherapy Part 3 – Atezolizumab Does Not Worsen Patient Reported Quality of Life for Early Stage Triple Negative Breast Cancer
By Karuna Jaggar, Former Executive Director and SABCS Guest Writer
Atezolizumab (brand name Tencentriq) was the first immunotherapy approved for breast cancer, just over a year and a half ago, as noted in my first immunotherapy blog post, for metastatic triple negative breast... Read more
Posted in Articles
SABCS 2020: Immunotherapy Part 2 – Pembrolizumab Can Be Paired With Any Partner Chemo
By Karuna Jaggar, Former Executive Director and SABCS Guest Writer
As explained in the prior blog post, immunotherapy seeks to harness the immune system to recognize and target cancer cells. The immunotherapy drug pembrolizumab (brand name Keytruda) is a checkpoint inhibitor... Read more
Posted in Articles
SABCS 2020: The Hallmarks of Cancer and the Hope of Immunotherapy
By Karuna Jaggar, Former Executive Director and SABCS Guest Writer
Cancer is a complex disease that includes breakdowns in multiple biological systems that allow tumors to grow. Understanding these mechanisms, sometimes referred to as the “Hallmarks of Cancer,” gives... Read more
Posted in Articles
SABCS 2020: Why Mammograms Can’t Fix Breast Cancer Disparities
By Jayla Burton, Program Officer
The growing attention to breast cancer disparities for Black women has resulted in an increase in marketing campaigns targeting women of color telling us that we must get screened for breast cancer. For many people, at first this sounds like... Read more
Posted in Articles
SABCS 2020: Helping Patients by Doing Less: No Chemo Needed for Even More Breast Cancers
By Karuna Jaggar, Former Executive Director and SABCS Guest Writer
Good news for many postmenopausal women with early stage, hormone positive breast cancer. Two new studies presented at the 2020 the San Antonio Breast Cancer Symposium (SABCS) confirm that the majority of these... Read more
Posted in Articles
a project of Breast Cancer Action